Avidity Partners Management’s Biohaven BHVN Stock Holding History

Avidity Partners Management’s Portfolio BHVN Stock Details BHVN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-145,000	Closed	-$3.49M	–	61
2025 Q1	$3.49M	Sell	145,000 -77,900	-35%	-$2.75M	0.66%	46
2024 Q4	$8.33M	Sell	222,900 -242,100	-52%	-$11.3M	0.82%	44
2024 Q3	$23.2M	Buy	465,000 +15,000	+3%	+$584K	1.19%	35
2024 Q2	$15.6M	Buy	450,000 +375,000	+500%	+$14.8M	0.66%	54
2024 Q1	$4.1M	Sell	75,000 -1,073,308	-93%	-$53.1M	0.13%	80
2023 Q4	$49.1M	Sell	1,148,308 -137,092	-11%	-$4.26M	1.79%	23
2023 Q3	$33.4M	Sell	1,285,400 -39,600	-3%	-$823K	1.35%	35
2023 Q2	$31.7M	Sell	1,325,000 -162,200	-11%	-$2.79M	1.11%	39
2023 Q1	$20.3M	Sell	1,487,200 -4,800	-0.3%	-$76.4K	0.67%	47
2022 Q4	$20.7M	Buy	+1,492,000	New	+$21.1M	0.45%	51

Other funds holding BHVN

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Stifel Financial St. Louis, Missouri $120B AUM 27.84% 1-Year Est. Return

SCM

Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return

Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Bellevue Group Kuesnacht, Switzerland $4.75B AUM 68.58% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return

Avidity Partners Management's BHVN Position: Q2 2025 in Review

Avidity Partners Management sold out of Biohaven (BHVN) in Q2 2025, closing a stake of 145,000 shares — an estimated $3.49M sold.

Avidity Partners Management first reported a position in BHVN in Q4 2022 and held it in 10 quarters. The position peaked at $49.1M in Q4 2023. 249 funds tracked by Wall St. Rank hold BHVN as of Q2 2025.

Avidity Partners Management reported no remaining Biohaven position as of Q2 2025 after selling out during the quarter.
Avidity Partners Management sold 145,000 Biohaven shares in Q2 2025, an estimated $3.49M.
Avidity Partners Management first reported a position in Biohaven in Q4 2022 and held it in 10 quarters.
Avidity Partners Management's Biohaven position peaked at $49.1M in Q4 2023.
249 funds tracked by Wall St. Rank held Biohaven as of Q2 2025.

Based on Avidity Partners Management's 13F filing for Q2 2025, filed 14 Aug 2025.